PureTech Health plc (PRTC) Estados Financieros e Histórico

PureTech Health plc (PRTC) — Precio $17.38 HealthcareBiotechnology — NASDAQ

Últimos resultados publicados:

Estados financieros detallados de PureTech Health plc (PRTC): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.

Resumen del Análisis

PureTech Health plc registró ingresos de $4.7M en el último ejercicio fiscal, con un CAGR de 5 años del -11.0%.

Márgenes de los últimos 12 meses: margen bruto -471.2%, margen operativo -21.2%, margen neto -23.6%.

Al precio actual de $17.38, PRTC presenta beneficios negativos (P/E no significativo) y un ROE del -31.83%. La capitalización bursátil es de $4.2B.

Cuenta de Resultados (10 años)

Año2016201720182019202020212022202320242025
Ingresos$4.4M$650000$16.4M$8.7M$8.3M$10.0M$2.1M$3.3M$4.8M$4.7M
Coste de Ventas$1.6M$71.0M$77.4M$85.8M0$110.5M$152.4M$4.9M$3.6M0
Beneficio Bruto$2.9M-$70.4M-$61.0M-$77.2M$8.3M-$100.5M-$136.8M-$1.6M$1.3M$4.7M
I+D$41.2M$71.7M$57.3M$65.2M$61.2M$81.5M$116.1M$96.2M$54.3M$45.7M
Generales y Administrativos$37.2M$46.3M$24.4M$34.9M$26.5M$30.8M$35.7M$48.4M$27.5M$20.7M
Gastos Operativos$78.4M$116.1M$120.4M$144.1M$127.9M$160.3M$61.0M$54.6M$140.4M$103.2M
Beneficio Operativo-$73.9M-$115.4M-$104.0M-$135.4M-$119.5M-$150.3M-$197.8M-$146.2M-$136.1M-$98.5M
EBITDA-$74.8M-$40.8M-$65.3M$487.8M$62.7M$26.7M-$188.9M-$11.6M$37.4M-$61.8M
Gastos por Intereses$6.8M$10.2M$14.8M$4.1M$2.9M$4.7M$4.0M$13.5M$10.0M$45.8M
Beneficio Antes de Impuestos-$83.2M-$70.7M-$68.4M$478.5M$19.0M-$59.0M-$92.8M-$36.1M$23.8M-$110.9M
Impuestos-$1.6M-$14000$2.2M$112.4M$14.4M$3.8M-$55.7M$30.5M-$4.0M-$842000
Beneficio Neto-$48.8M$30.9M-$43.7M$421.1M$6.0M-$60.6M-$50.4M-$65.7M$53.5M-$109.7M
BPA$-2.10$1.10$-1.60$14.40$0.20$-2.10$-1.80$-2.40$2.00$-46.00
BPA Diluido$-2.10$1.10$-1.60$14.40$0.20$-2.10$-1.80$-2.40$2.00$-46.00
Acciones en Circulación (Diluidas)$23.0M$23.9M$27.4M$29.2M$29.3M$28.7M$28.5M$27.6M$27.0M$2.4M

Cuenta de Resultados (Trimestral)

Año2024-Q22024-Q42025-Q22025-Q4
Ingresos$288000$4.0M$1.9M$2.8M
Beneficio Bruto-$38.6M$43.0M-$23.0M$1.1M
Beneficio Operativo-$66.4M-$69.7M-$47.9M-$50.4M
EBITDA-$64.6M$102.0M-$46.2M-$48.8M
Beneficio Neto-$41.8M$95.3M-$44.6M-$64.9M
BPA$-1.50$3.50$-1.90$-26.90
BPA Diluido$-1.50$3.50$-1.90$-26.90

Balance (10 años)

Año2016201720182019202020212022202320242025
Caja y Equivalentes$63.0M$72.6M$117.1M$132.4M$403.9M$465.7M$149.9M$191.1M$280.6M$254.1M
Inversiones a Corto$219.4M$117.0M$133.8M$30.1M00$200.2M$136.1M$86.7M$24.8M
Cuentas por Cobrar$125000$1.8M$1.3M$2.3M$2.9M$3.6M$22.4M$2.4M$12.9M$8.1M
Inventario-$1.9M-$2.7M-$1.3M00$28.0M0000
Activos Corrientes$288.2M$198.1M$259.8M$168.8M$414.3M$501.8M$386.2M$347.2M$386.3M$305.0M
Inmovilizado Material$6.9M$6.9M$8.3M$43.8M$42.9M$43.9M$37.2M$19.4M$15.1M$11.5M
Fondo de Comercio0000000000
Activos Intangibles$3.5M$3.3M$3.1M$625000$899000$987000$831000$906000$601000$601000
Activos Totales$298.7M$339.8M$441.8M$941.2M$990.0M$946.0M$702.6M$694.0M$602.6M$534.7M
Cuentas por Pagar$2.1M$3.4M$4.6M$11.1M$8.9M$11.3M$26.5M$14.6M$5.5M$3.1M
Deuda a Corto$7.0M$7.5M$12.0M$1.5M$26.5M$5.5M$7.5M$3.7M$4.1M$4.9M
Pasivos Corrientes$204.1M$273.9M$265.8M$139.2M$180.9M$226.1M$96.9M$51.4M$41.4M$46.3M
Deuda a Largo00$3570000$14.8M$14.3M$10.2M000
Pasivos Totales$206.3M$275.8M$274.8M$290.8M$336.5M$361.9M$155.1M$235.7M$194.7M$229.0M
Reservas-$160.3M-$127.9M-$167.7M$254.4M$260.4M$199.9M$149.5M$83.8M$32.5M$61.3M
Patrimonio Neto$177.7M$214.3M$275.5M$668.0M$669.7M$593.5M$542.2M$464.1M$414.7M$312.1M
Deuda Total$7.0M$7.5M$12.4M$39.3M$76.6M$52.7M$46.9M$25.3M$22.4M$19.6M
Deuda Neta-$275.4M-$182.2M-$238.5M-$123.2M-$327.3M-$413.0M-$303.2M-$301.8M-$344.9M-$259.3M
Capital Circulante$84.1M-$75.8M-$6.0M$29.6M$233.4M$275.7M$289.3M$295.8M$344.9M$258.7M

Balance (Trimestral)

Año2024-Q22024-Q42025-Q22025-Q4
Caja y Equivalentes$308.5M$280.6M$262.2M$254.1M
Activos Totales$580.0M$602.6M$553.2M$534.7M
Pasivos Totales$273.7M$194.7M$184.2M$229.0M
Patrimonio Neto$315.9M$414.7M$376.0M$312.1M
Deuda Total$27.3M$22.4M$21.1M$19.6M

Flujo de Caja (10 años)

Año2016201720182019202020212022202320242025
Beneficio Neto-$81.6M-$70.7M-$70.7M$366.1M$4.6M-$62.7M-$37.1M-$65.7M$27.8M-$110.0M
Amortizaciones$1.6M$2.1M$2.8M$6.7M$6.6M$7.3M$8.9M$4.9M$3.6M$3.4M
Compensación en Acciones$10.2M$11.8M$12.6M$14.5M$10.7M$13.9M$14.7M$4.4M$22.9M$8.2M
Cambio en Capital Circulante$1.9M$3.0M$10.0M$15.0M-$8.5M$861000$15.9M$17.5M-$10.2M-$3.1M
Flujo de Caja Operativo-$58.0M-$88.7M-$72.8M-$98.2M-$131.8M-$158.3M-$178.8M-$105.9M-$134.4M-$85.3M
Inversiones (CapEx)-$3.7M-$2.2M-$4.5M-$12.5M-$5.4M-$5.7M-$2.2M-$245000-$11000-$6010
Adquisiciones0-$16.3M-$13.4M-$16.0M-$10.0M$321000-$20.4M-$13.8M-$106.0M$269628
Recompra de Acciones0-$66000-$35000-$1.3M0-$13.3M-$26.5M-$19.6M-$107.6M-$2.1M
Dividendos Pagados0-$91000-$8000-$112000000000
Flujo de Caja Libre-$61.7M-$90.9M-$77.3M-$110.7M-$137.3M-$163.9M-$181.0M-$106.2M-$134.4M-$85.3M

Flujo de Caja (Trimestral)

Año2024-Q22024-Q42025-Q22025-Q4
Flujo de Caja Operativo-$80.0M-$54.4M-$46.3M-$38.5M
Inversiones (CapEx)$4-$11000-$3-$5978
Flujo de Caja Libre-$80.0M-$54.4M-$46.3M-$38.5M
Dividendos Pagados0000
Compensación en Acciones$4.6M$18.2M$4.7M0

Crecimiento y Márgenes (10 años)

Año2016201720182019202020212022202320242025
Crecimiento Ingresos (anual)-85.3%+2418.6%-46.9%-4.0%+19.6%-79.1%+59.3%+45.0%-3.5%
Crecimiento Beneficio Neto (anual)+163.3%-241.4%+1064.7%-98.6%-1111.8%+16.8%-30.5%+181.4%-305.1%
Crecimiento BPA (anual)+152.4%-245.5%+1000.0%-98.6%-1150.0%+14.3%-33.3%+183.3%-2400.0%
Cambio en Acciones (anual)+4.1%+14.6%+6.5%+0.4%-2.1%-0.6%-3.0%-2.4%-91.1%
Crecimiento FCF (anual)-47.2%+14.9%-43.2%-24.0%-19.4%-10.4%+41.3%-26.6%+36.5%
Margen Bruto64.6%-10828.5%-372.8%-888.1%100.0%-1007.0%-6546.2%-48.1%26.0%100.0%
Margen Operativo-1668.4%-17756.9%-635.4%-1558.5%-1433.1%-1506.0%-9464.4%-4390.4%-2818.9%-2114.7%
Margen EBITDA-1688.2%-6275.5%-398.7%5614.4%751.6%267.6%-9038.9%-349.2%774.3%-1326.5%
Margen Neto-1101.2%4749.1%-266.7%4847.4%71.8%-606.9%-2409.3%-1972.9%1108.3%-2355.4%
Margen FCF-1392.7%-13978.3%-472.1%-1274.1%-1645.5%-1642.8%-8658.8%-3188.0%-2783.3%-1831.6%
Tasa Impositiva Efectiva1.9%0.0%-3.2%23.5%75.9%-6.4%60.1%-84.5%-16.9%0.8%

Datos por Acción (10 años)

Año2016201720182019202020212022202320242025
FCF por Acción$-2.69$-3.80$-2.82$-3.79$-4.69$-5.72$-6.36$-3.84$-4.98$-35.44
Dividendo por Acción$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Acciones en Circulación (Básicas)$23.0M$23.9M$27.3M$29.2M$29.3M$28.7M$28.0M$27.6M$27.0M$2.4M

Qué mirar en Biotech

La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.

Rentabilidad

Rentabilidad sobre capital-31.83%
Rentabilidad sobre capital invertido-19.64%
Rentabilidad sobre activos-20.48%
Margen bruto-471.15%
Margen operativo-2115.41%
Margen neto-2355.50%

Salud financiera

Deuda / Patrimonio0.06
Ratio corriente6.59
Piotroski F-Score4
Altman Z-Score0.25

Ratios Clave (10 años)

Año2016201720182019202020212022202320242025
P/E-18.3335.00-24.062.67264.71-17.62-17.72-11.749.23-0.36
P/VC4.974.293.811.682.361.791.651.681.200.13
P/V199.421415.1564.16129.30189.60106.26426.98233.82103.108.60
Margen Bruto64.6%-10828.5%-372.8%-888.1%100.0%-1007.0%-6546.2%-48.1%26.0%100.0%
Margen Operativo-1668.4%-17756.9%-635.4%-1558.5%-1433.1%-1506.0%-9464.4%-4390.4%-2818.9%-2114.7%
Margen Neto-1101.2%4749.1%-266.7%4847.4%71.8%-606.9%-2409.3%-1972.9%1108.3%-2355.4%

Empresas relacionadas: CLYM · GNTA · INBX · IVA · KROS · SLN · TARS

Explorar sector: Healthcare · Biotechnology

Más secciones de PRTC: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos

Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones